<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04700865</url>
  </required_header>
  <id_info>
    <org_study_id>20/09000-7</org_study_id>
    <nct_id>NCT04700865</nct_id>
  </id_info>
  <brief_title>The South-Norway Atrial Fibrillation Screening Study</brief_title>
  <acronym>AFstudien</acronym>
  <official_title>The South-Norway Atrial Fibrillation Screening Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sorlandet Hospital HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sorlandet Hospital HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder. The most&#xD;
      serious common complication of AF is ischemic stroke.The aim of this study is to investigate&#xD;
      the yield of AF screening with a continuous ECG monitor (ECG247) and to estimate the&#xD;
      prevalence of silent AF&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder. The most&#xD;
      serious common complication of AF is ischemic stroke. Many AF cases are undiagnosed due to&#xD;
      the asymptomatic and intermittent nature of AF (silent AF). Today there is no simple and&#xD;
      inexpensive method of detecting silent AF and thus preventing stroke. The ECG247 Sensor is a&#xD;
      new Norwegian digital clinical tool for out-of-hospital self-testing of AF. The innovation&#xD;
      project has originated from the University of Agder and Sorlandet Hospital. The COVID19&#xD;
      pandemic is realizing more than ever the need for single-use self-testing out-of-hospital&#xD;
      diagnostic tools.&#xD;
&#xD;
      The general aim of this open non-randomized study is to investigate the yield of AF screening&#xD;
      with a continuous ECG monitor (ECG247) and to estimate the prevalence of silent AF in a&#xD;
      cohort of 1500 65-year-old individuals with additional risk factors for stroke.&#xD;
&#xD;
      If the study results indicate that easy-to-use continuous AF-screening-devices designed for&#xD;
      self-testing can identify people with previously unrecognized AF, this study may contribute&#xD;
      to change the approach to screening for AF in the community. Consequently, the study may&#xD;
      prevent stroke in the future. By preventing stroke, major personal and socio-economic&#xD;
      consequences can be avoided.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 23, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of AF</measure>
    <time_frame>During procedure</time_frame>
    <description>AF during procedure</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Examination</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Continuous ECG monitoring for minimum 3 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AF screening</intervention_name>
    <description>Continous ECG monitoring for minimum 3 days</description>
    <arm_group_label>Examination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;65 years&#xD;
&#xD;
          -  Diabetes, heart failure, hypertension, previous stroke/TIA or other cardiovascular&#xD;
             disease (minimum 1 risk factor)&#xD;
&#xD;
          -  Informed written consent for participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic AF&#xD;
&#xD;
          -  Lack of ability to cooperate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarle Jortveit, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sorlandet Hospital Arendal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jarle Jortveit, PhD</last_name>
    <phone>+4799450714</phone>
    <email>jarle.jortveit@sshf.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sorlandet Hospital</name>
      <address>
        <city>Arendal</city>
        <zip>4809</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarle Jortveit, PhD</last_name>
      <phone>+4799450714</phone>
      <email>jarle.jortveit@sshf.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.afstudien.no</url>
    <description>Related Info</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 26, 2020</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

